个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

【已隐藏】Molecular Characteristics and Response to Diverse EGFR TKIs of NSCLC Patients Harboring EGFR E709-T710delinsX

| 认领 | 导出 |

本文已应作者要求隐藏

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Fang, W.[1] * ; Xu, C.[2] ; Li, X.[3] ; Zeng, L.[4] ; Wang, X.[5] ; Li, J.[6] ; Sun, Y.[7] ; Zhang, Q.[8] ; Yang, N.[4] ; Huang, Y.[1] ; Li, S.[9] ; Ye, J.[9] ;
机构： [1]Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou/CN [2]Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing/CN [3]The First Affiliated Hospital of Zhengzhou University, Zhengzhou/CN [4]The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha/CN [5]Zhongda Hospital Southeast University, Nanjing/CN [6]Sichuan Cancer Hospital and Institute, Chengdu/CN [7]Affiliated Guangdong Provincial People’s Hospital, Guangzhou/CN [8]Jiaxing First People’s Hospital, Jiaxing/CN [9]Burning Rock Biotech, Guangzhou/CN
出处：
ISSN：

关键词： Next Generation Sequencing EGFR E709-T710delinsX EGFR TKIs

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou/CN
推荐引用方式(GB/T 7714)：
Fang W.,Xu C.,Li X.,et al.Molecular Characteristics and Response to Diverse EGFR TKIs of NSCLC Patients Harboring EGFR E709-T710delinsX[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(3):S607-S608.
APA：
Fang, W.,Xu, C.,Li, X.,Zeng, L.,Wang, X....&Ye, J..(2021).Molecular Characteristics and Response to Diverse EGFR TKIs of NSCLC Patients Harboring EGFR E709-T710delinsX.JOURNAL OF THORACIC ONCOLOGY,16,(3)
MLA：
Fang, W.,et al."Molecular Characteristics and Response to Diverse EGFR TKIs of NSCLC Patients Harboring EGFR E709-T710delinsX".JOURNAL OF THORACIC ONCOLOGY 16..3(2021):S607-S608

相关文献

[1]Molecular Characteristics and Response to Diverse EGFR TKIs of NSCLC Patients Harboring EGFR E709-T710delinsX [2]Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients [3]中国前列腺癌患者基因检测专家共识（2018年版） [4]The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses [5]Non-invasive plasma testing for CD274 UTR structural variations by next-generation sequencing in cancer [6]Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing. [7]ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. [8]Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas [9]Detection of ERBB2 (HER2) amplification by next-generation sequencing (NGS) in patients (pts) with gastrointestinal (GI) cancer [10]Comparison of NGS and FISH Platforms to Test MET Amplification in Chinese Lung Cancer Patients: A Prospective Study

资源点击量：53699 今日访问量：0 总访问量：4607 更新日期：2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号